Role and timing of second-line therapies for patients with recurrent platinum-resistant ovarian epithelial cancer.
CONCLUSION: The efficacy of second-line therapy for recurrent platinum-resistant OEC is rather poor and the feasibility and efficacy of second operation are to be further explored.
PMID: 29953793 [PubMed - in process]
Source: European Journal of Gynaecological Oncology - Category: OBGYN Tags: Eur J Gynaecol Oncol Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Epithelial Cancer | OBGYN | Ovarian Cancer | Ovaries